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Abstract  
Health risks associated with inhalation and deposition of biological materials have been a 
topic of great concern due to highly publicized cases of inhalation anthrax, of new regula-
tions on the release of particulate matter, and to increased concerns on the hazards of in-
door air pollution. Here, we present an evaluation of the sensitivity of two immortal cell lines 
(A549, human lung carcinoma epithelia) and NR8383 (rat alveolar macrophages) to a variety 
of bacterial-derived inhalation hazards and simulants including etoposide, gliotoxin, strep-
tolysin O, and warfarin. The cell response is evaluated through quantification of changes in 
mitochondrial succinate dehydrogenase activity, release of lactate dehydrogenase, initiation 
of apoptosis, and through changes in morphology as determined by visible light microscopy 
and scanning electron microscopy. These cells display dose–response relations to each toxin, 
except for triton which has a step change response. The first observable responses of the ep-
ithelial cells to these compounds are changes in metabolism for one toxin (warfarin) and al-
terations in membrane permeability for another (gliotoxin). The other four toxins display a 
similar time course in response as gauged by changes in metabolism and loss of membrane 
integrity. Macrophages are more sensitive to most toxins; however, they display a lower level 
of stability. This information can be used in the design of cell-based sensors responding to 
these and similar hazards. 
Keywords: Human lung cells, Cell culture, Toxicity monitoring 
Introduction 
Public concern for the risks associated with inhalation of biohazardous materials has 
been raised due to several highly publicized cases of presumed exposure to anthrax, 
combustion wastes, and indoor air pollution. Health and safety risks of inhaling such 
materials are typically evaluated through extensive laboratory study. When the identity 
and composition of the potential toxin are unknown, this often requires extensive and 
digitalcommons.unl.edui it l .
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expensive analysis using numerous laboratory animals. Such methods cannot provide 
suitable monitoring of the health impact of transient factors. The lack of a rapid means 
to directly quantify the health impact of inhalation hazards has led to the development 
of environmental regulations based on easily quantified metrics, such as the mass of par-
ticulate matter, which do not directly correlate to health risks. Current methods of de-
tecting hazardous materials through traditional analytical procedures are lacking. New 
methods are required that can simultaneously detect multiple hazards (ranging across 
disparate chemical and biological classes) that can characterize functionality of the haz-
ard and that can predict impact on humans and animals that may be contacted [1]. 
To address the need for a means to monitor the potential impact of inhaling air of 
dubious quality, cell-based biosensing devices are being developed, utilizing cell cul-
tures that are responsive to many common inhalation hazards. These portable devices 
contain living biological cells that respond through physiological changes induced by 
exposure to environmental hazards including toxicants, pathogen, or other agents [1]. 
Such an approach can evaluate the potential toxicity of compounds relatively quickly, 
outside of the laboratory environment, inexpensively, and without the need for highly 
trained technicians. These biosensors are composed of two primary elements: a cellular 
layer which serves as a biological recognition element and a photometric sensor that 
quantifies the response of the cells to potential toxins. 
Methods for detecting cell response include optical, electrical, and chemical means. 
Many of the recent works have focused on quantifying electrical responses of neurons 
or myocytes to biochemical agents. One group [2, 3] has used an integrated silicon-
polydimethylesiloxane cell cartridge to monitor the action potential of cardiomyocytes ex-
posed to biochemical agents. Thach and coworkers [4] found that both neural precursor 
cells and peripheral blood mononuclear cells were responsive for detection of Sindbis virus. 
In the present study, we report on the response of human A549 lung carcinoma ep-
ithelial cells and rat alveolar macrophage cells to a wide range of chemicals that mimic 
the effects of biological agents. This response is quantified through standard biochemi-
cal analyses. Inhalation hazards evaluated include the following. Gliotoxin is a secondary 
metabolite produced from Aspergillus and Penicillium species and is present in agricul-
tural dusts from plant surfaces, stored hay and grain, and compost with spores often in 
the respirable range. Acute exposures to gliotoxin are associated with respiratory aller-
gic symptoms, while chronic exposures have been linked to aspergillosis, an immuno-
suppresion disease characterized by cough, fever, and shortness of breath [5, 6]. Methyl 
methansesulfonate (MMS) is an alkylating agent that causes single- and double-strand 
DNA breaks and developmental toxicity following exposure [7]. Streptolysin O is a thiol-
activated cytolysin isolated from Streptococcus pyogenes which binds to cholesterol on 
the cell surface, permeabilizes cell membranes, and causes apoptosis [8]. Etoposide (VG-
16) is a topoisomerase II inhibitor that binds to and cleaves DNA causing cross-linked 
DNA fragments. It is highly toxic to actively replicating cells and so is used as a chemo-
therapeutic agent to treat certain types of cancers such as leukemia. Triton X-100 is a 
detergent and has been used as a cytotoxic agent to induce cell death through extrage-
nomic mechanisms [9]. Detergents affect the cell membrane by solubilizing the lipids 
through the disruption of hydrophobic contact, thus destroying the lipid bilayer. Warfa-
rin (3-(a-acetonylbenzyl)-4-hydroxycoumarin) is an anticoagulant rodenticide used for 
controlling rats and house mice in homes, agricultural facilities, and industrial sites. Ab-
sorption by the lungs may result in hemorrhagic effects. 
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Materials and Methods 
Cell Culture 
A human lung carcinoma epithelia (A549) cell line and a rat alveolar macrophage 
(NR8383) line were maintained in Dulbecco’s modified Eagle’s media (Sigma Chemi-
cal Co., St. Louis, MO, USA), supplemented with 10% fetal bovine serum and 1% antibi-
otic–antimycotic solution (Sigma) in T-25 flasks at 37 °C and 5% CO2. Relatively young 
cell cultures (passages less than 25) were used to ensure a consistent response [10, 11]. 
For A549 cytotoxicity experiments, newly confluent cell layers were trypsinized, resus-
pended in medium, and seeded in 96-well plates with 100 μL/well. Plates were seeded 
with 12,500 cells per well, which corresponds to 25% confluence over each well in the 
plate, and then allowed to grow to confluence for 48 h at 37 °C and 5% CO2. 
For NR8383 cytotoxicity experiments, a variation on procedures was necessary since 
these cells do not form strong attachments to surfaces. Cells were harvested, resus-
pended in fresh medium, and seeded in 96-well plates with 100 μL/well. Plates were 
seeded with 12,500 cells per well and then allowed to replicate for 48 h at 37 °C and 
5% CO2. After 48 h of growth, the number of cells per well was approximately 50,000. 
All exposures were performed in serum-free medium as serum can interfere with 
dosages [12, 13]. Two columns of the 96-well plate (16 wells) were devoted to a control. 
Pure phosphate-buffered saline (PBS) solution was used instead of the toxic stock solu-
tion and were otherwise treated identical to the other wells. 
Toxins 
Gliotoxin is a secondary metabolite produced from Apergillus and was used to simu-
late a fungal exposure. Streptolysin O is a thiol-activated cytolysin isolated from S. pyo-
genes that permeabilizes cell membranes and causes DNA fragmentation. Streptolysin 
O binds to cholesterol on the surface of the cell membrane; multiple binding events 
lead to aggregation on the cell surface leading to formation of small pores on the cell 
membrane leading to cell swelling. Etoposide and methyl methansesulfonate are not 
naturally found in the environment but were used to simulate an exposure to genotoxic 
agents. Triton X-100 is a detergent and was used to simulate a cytotoxic agent. Warfa-
rin (3-(a-acetonylbenzyl)-4- hydroxycoumarin) is an anticoagulant rodenticide used for 
controlling rats and mice in homes, agricultural facilities, and in industrial sites. Unless 
noted otherwise, all reagents were obtained from Sigma Chemical Co., St. Louis, MO. 
Formulations of each toxin were prepared fresh before each experiment. MMS and 
triton were prepared in PBS at ten times the concentration to be evaluated on cultures. 
Etoposide was dissolved in a 2% dimethylsulfoxide (DMSO) solution; gliotoxin was dis-
solved in a 95% ethanol solution; streptolysin O was prepared in a phosphate buffer 
with dichlorodiphenyltrichloroethane [14]; and warfarin was dissolved in 5% acetone. 
These alternate solutions were developed to permit sufficient solubility of each toxin 
to reach concentrations beyond the TC50 value for each. The impact of DMSO, acetone, 
ethanol, and the streptolysin buffer were evaluated at concentrations matching those 
employed for exposures; typically, a 1:10 dilution is made with culture media for the 
exposures. No significant toxic effects were obtained (data not shown) at these expo-
sure concentrations.  
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Cytotoxicity Quantification 
Cells were exposed for various times ranging from 2 to 72 h before the response was 
quantified. Cellular metabolism was evaluated using an 3(4,5-dimethylthiazol-2-yl) 2,5- 
diphenyltetrazolium bromide (MTT) assay which used 5 mg/mL reagent in PBS prepared 
and filtered to remove undissolved solids immediately before each use. Ten microliters 
of MTT solution was added to the 100 μL of medium in each well, and the plate was 
incubated at 37 °C for 2 h. Absorbance was measured at 540 nm on a multiwell plate 
reader. Each measurement was performed with at least eight replicates for each data 
point; curves represent composites of two to three separate experiments. 
NR8383 macrophage cell analysis was performed using a WST-1 assay (Roche Di-
agnostics GmbH, Mannheim Germany) following manufacturer’s instructions and pre-
sented in greater detail previously [13, 15]. 
Cell death was quantified using a commercial nonradioactive lactate dehydrogenase 
(LDH) release assay (Roche Diagnostics GmbH, Mannheim Germany); manufacturer’s 
procedures were followed. LDH release is an indicator of damage to plasma membrane 
integrity. Cell health was evaluated as a ratio of LDH release in response to toxins com-
pared to that from lysed cells. 
Mechanisms of cell death were investigated using a fluorescent-based assay (Onco-
gene Research Products, Boston, MA, USA) utilizing two fluorophores, annexin V-floures-
cein isothiocyanate (FITC) and propidium iodide. Annexin V-FITC identifies early apop-
totic cells by binding to phosphatidyl serine present on the outer cell membrane only 
during early stages of apoptosis. Propidium iodide stains the DNA of cells with dam-
aged membranes and identifies all dead cells. These fluorophores can differentiate be-
tween oncotic (nongene directed) and apoptotic (gene directed) cell death. The fluores-
cence-based assay was performed on confluent monolayers of A549 cells attached to 
polystyrene surfaces of a 12-well tissue culture treated plate (VWR) and exposed to tox-
ins for 6–16 h. Cell counts of controls and exposed cells were tabulated and compared 
relative to the brightfield image (no fluorescence), which was used to determine total 
cell numbers in a microscopy field. Ten random fields were counted for each sample. 
Scanning electron microscopy (SEM) images were collected on healthy and exposed 
A549 cells. Cells were grown to confluence on glass slides placed within a petri dish for 
48 h after seeding. Cultures were exposed to toxins for 24 h and then prepared for SEM 
following standard procedures as described previously [13]. A549 cells were seeded onto 
2.5×2.5 cm cover slips at a cell density of 25,000 cells per cover slip. Concentrations of 
etoposide, MMS, and triton above and below the TC50 values were selected and cells 
were exposed for 24 h following procedures described above. TC50 was defined as the 
concentration of toxicant causing a decrease in cellular function by 50% as gauged by 
metabolic assay. Images were viewed under the SEM using an accelerating voltage of 
12 kV, condenser lens at 1–3 o’clock, and working distance ranging from 20 to 24 mm. 
All images were saved with a resolution of at least 640×640 pixels. 
The presence of statistical differences between groups was determined using anal-
ysis of variance, with Newman–Keuls method as the post hoc test [16]. Each value pre-
sented in figures below represents the mean±standard deviation for between eight 
and 16 experimental treatments. The level of statistical significance employed was ei-
ther P<0.05 or P<0.01. 
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Results 
The sensitivity of transformed lung cell cultures to a variety of toxins was evaluated through 
analysis of morphology (SEM), metabolic activity (MTT), membrane integrity (LDH release 
and propidium iodide uptake), and initiation of apoptosis (annexin V assay). Cell health is 
presented as a ratio the function of exposed cells to that of unexposed controls. 
The behavior of A549 cells and NR8383 cells to varying concentrations of toxins for 
24 h shows a clear dose response. For both cells, gliotoxin generates a response at the 
lowest concentrations (Table 1). Shown here are the results for streptolysin O only (Figure 
1); similar behavior is seen for response to the other toxins tested. In general, NR8383 
macrophages are more sensitive to toxins and generate a response at lower concentra-
tions. Note, however, that these macrophage responses display greater variability in sen-
sitivity and in several cases demonstrate a step change response rather than a smooth 
decline compared with the more predictable response of the A549 epithelial cells. Tem-
poral studies were performed to gain insight into mechanisms of cellular response. 
The temporal response of A549 cells to varying concentrations of each toxin is shown 
in Figure 2. Etoposide (Figure 2a) caused little decline in cellular metabolic activity af-
ter 2 h of exposure. A dose response appeared after 8 h of exposure. Metabolic activity 
Table 1 Summary of TC50 values for 24 h exposure and gene expression changes in response to com-
pounds tested here (Boesewetter et al. [7]).
Toxin  Predominant alterations in gene expression TC50 value TC50 value
    (Boesewetter et al. [7]) for A549 for NR8383
Etoposide  Cell cycle, DNA repair enzymes, electron transport, 1.0 mM  0.06 mM 
    and apoptotic pathways
Gliotoxin  Metabolic enzymes, ion channels, signaling pathways, 0.0005 mM  0.00003 mM 
    cell adhesion
MMS  Cell cycle, protein translation, DNA repair enzymes, 1.1 mM  0.75 mM 
    and apoptotic pathways, immune response cascades
Streptolysin O  Ion channel proteins, structural proteins, signal trans- 680 units  75 units 
    duction, protein modification, and metabolic enzymes
Triton X-100  Extracellular matrix, ion channel proteins, structural 0.09 mM  0.05 mM 
    proteins, cell cycle, and metabolic enzymes
Figure 1. Response of A549 and 
NR8383 cells to toxins quantified 
as metabolic activity after 24 h of 
exposure to streptolysin O
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continued to decline past 48 h of exposure. The temporal behavior of declined metab-
olism is supported by LDH release measurements (Figure 3a) in response to etoposide. 
However, nearly the same amounts of LDH were quantified after low and high etopo-
side exposures. 
Exposure of the A549 cells to either 0.01 or 0.1 mM etoposide for 16 h led to a sig-
nificant increase in the number of cells in the early stages of apoptosis (Figure 4a). Very 
few cells were stained by propidium iodide at each concentration suggesting that eto-
poside caused minimal loss of membrane integrity. At 0.01 mM, approximately 16% of 
the cells were shown to be exhibiting early stages of apoptotic mechanisms compared 
to almost 30% after exposure to 0.1 mM etoposide. 
Upon exposure to etoposide, the A549 cells underwent a moderately rapid morpho-
logical change as displayed in Figure 5. When exposed to concentrations of 0.5 mM 
for 30 min (not shown), cell morphology changed little compared to that of unexposed 
controls (Figure 5a); however, after exposure for 14 to 24 h (Figure 5d, e, respectively) 
the cells showed a sizeable change in morphology with most cells highly rounded and 
Figure 2. Temporal response of A549 cell metabolic activity after exposure to: a) etoposide; b) gliotoxin; 
c) MMS; d) streptolysin O; e) triton; f) warfarin
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condensed (Figure 5f). Fewer cells were present on the surface after 24 h (Figure 5e) 
than at 14 h (Figure 5d); all cultures began with a confluent monolayer. 
Gliotoxin (Figure 2b, Table 1) elicited decreases in metabolic activity of at least 20% 
for all exposure concentrations within 4 h of exposure. Above a concentration of 0.001 
mM, a large decrease was apparent after 15 h, but activity was still on the order of 40%. 
Only after 24 h of exposure, did metabolism decline to very low levels. This long time to 
respond is not fully supported by LDH release measurements (Figure 3b) which showed 
that nearly 70% of the available LDH was released within 4 h of exposure to high glio-
toxin concentrations. 
A549 cells exposed to 0.005 mM gliotoxin for 6 h displayed only a small portion of 
cells labeled with the annexin V-FITC, indicative of early apoptosis (Figure 4b). An even 
smaller proportion displayed loss of membrane integrity. This supports the MTT results 
but not the LDH release measurements. 
Exposure to MMS yielded minimal effect after 2 h but significant decline in meta-
bolic activity (Figure 2c, Table 1) and LDH release (Figure 3c) after 8 h for the highest 
Figure 3. Temporal response of A549 cell LDH release in response to: a) etoposide; b) gliotoxin; c MMS; 
d) streptolysin O; e) triton; f) warfarin. Each measurement was performed with at least eight replicates 
for each data point.
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concentrations. Minimal LDH can be quantified after exposure to low concentrations of 
MMS. The differences in metabolic activity were more pronounced at the higher expo-
sure concentrations. A significant number of A549 cells exposed to 1.0 mM MMS for 16 
h displayed evidence of early apoptosis (Figure 4c). After 24 h of exposure, cell morphol-
ogy shows significant “blebbing” with a loss of cell–cell contact (Figure 5g–i). 
Exposure of A549 cells to streptolysin O concentrations below the TC50 of 680 units 
yielded a slow decline in cell viability. Culture metabolism (Figure 2d, Table 1) remained 
close to that of unexposed controls, except for those exposed to 400 units. Despite hav-
ing the membrane as the primary target for attack, streptolysin O induced little LDH re-
lease up to 6 h of exposure (Figure 3d). 
Triton X-100 caused a very rapid decline in culture metabolic activity for concentra-
tions above the TC50 level (Figure 2e, Table 1). Essentially no metabolic activity was appar-
ent after exposure to greater than 0.1 mM triton for 2.5 h or more. This was supported 
by the release of nearly all of the available LDH (Figure 3e). Lower concentrations of tri-
ton did promote significant declines in metabolic activity (Figure 2e), but these declines 
were apparent only after longer times of exposure. 
A549 cells exposed to 0.06 and 0.08 mM Triton for 6 h (Figure 4d) showed minimal 
annexin V-FITC staining compared to the unexposed control; however, a larger propor-
tion of cells stained with propidium iodide. At both these concentrations, metabolic ac-
tivity should have declined to 40% that of controls (Figure 2e). When exposed to low 
concentrations of Triton for up to 60 min (not shown), cell morphology changes little 
Figure 4. Response of A549 cells as gauged by annexin V-FITC (early apoptosis) and propidium iodide 
(PI) for loss of membrane integrity. a) Etoposide; b) gliotoxin; c) triton; d) MMS. Etoposide and MMS 
were evaluated after 16 h, while gliotoxin and triton were evaluated after 6 h.
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compared to that of unexposed controls (Figure 5a). After exposure to 0.1 mM Triton for 
24 h (Figure 5j–l), the cells lose their tight packing and show gross mechanical damage 
evidenced primarily by an apparent loss of large areas of the cell membrane. 
Figure 5. SEM of A549 cells exposed to biotoxins. a) control (×80); b) control (×250); c) control (×400); 
d) etoposide, 14 h, (×500); e) etoposide, 24 h, (×500); f) etoposide, 14 h, (×3,000); g) MMS, 24 h (×500); 
h) MMS, 24 h (×2,500); i) MMS, 24 h (×2,500); j) triton, 24 h (×500); k) triton, 24 h (×2,500); l) triton, 
24 h (×2,500)
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Warfarin acts slowly on A549 cells with minimal impact on metabolism seen after 
2 h of exposure; however, a dose response appears after 24 h of exposure (Figure 2f). 
This compound has minimal impact on the cell membrane as evidenced by the very 
low amount of LDH released regardless of time or exposure concentration (Figure 3f). 
Discussion 
These analyses provide information on the sensitivity of immortal cells (A549 human 
type II epithelia and rat alveolar macrophages) and on mechanisms and timing of dam-
age resulting from exposure to a variety of biochemical toxins. The biochemicals were 
selected based on their ability to induce different types of cellular damage and hence 
induce different cell response mechanisms. Cytotoxicity can be cell-type dependent 
[17], and so all toxins were matched here with either cellular barriers or potential tar-
gets. A549 cells are commonly applied as a cell culture tool for assessing potential in-
halation toxicity [18]. The metabolism of this epithelial layer is often one of the first cel-
lular functions altered by the presence of toxins [19]. 
In A549 cells, etoposide has been reported to induce double-strand DNA breaks after 
8 h while the cells remained viable [9]. Etoposide was shown to rapidly and profoundly 
upregulate p53, an inducer of apoptosis [20, 21], in the later phases of apoptosis but 
immediately before caspase-3 activation [21]. The result is that etoposide blocks the cell 
cycle in S-phase and G2-phase in normal and tumor cell lines. 
Our results suggest there is a moderately quick cell decline through apoptosis in re-
sponse to etoposide, which caused little decrease in cellular metabolic activity or LDH 
release after 2 h, but displayed a dose response after 8 h of exposure. Metabolic activ-
ity continued to decline through 48 h of exposure. Etoposide induced apoptosis in a do-
sedependent manner, suggesting a strong genetic component to the response. 
Gliotoxin is a fungal toxin that acts as an immunosuppressent, but its mechanism 
of action is largely unknown and varies based on the type of cell it encounters. A549 
cells were shown to have a concentration-dependant growth inhibition to gliotoxin 
[22] which could be attributed to reactive oxygen species generated through redox cy-
cling [23–25]. In rat macrophages and human colonic epithelial cells, gliotoxin inhibited 
NF-κB activation and significantly inhibited cytokine secretion when stimulated with li-
popolysaccharide [26]. 
The response to gliotoxin seen here was fairly slow, with only small declines in cell 
function after 4 h of exposure; however, substantial LDH was released within this time 
frame. This supports the mechanism of membrane damage but does not support the 
altered metabolic flux pattern at short times. As shown here, gliotoxin could induce on-
cotic cell death but only a small degree of apoptosis, even at fairly high concentrations. 
A possible mechanism of cell response to gliotoxin is damage to membrane lipids fol-
lowed by damage to intracellular proteins. The macrophages are significantly more sen-
sitive to gliotoxin than are the A549 cells (TC50 0.00003 mM for NR8383 and 0.0005 mM 
for A549). Of the compounds tested here, gliotoxin has the greatest difference in sensi-
tivity between these two cell types. This could be due to the different abilities of these 
cells to generate oxygen free radicals (higher in the macrophages). 
Methyl methansesulfonate is an alkylating agent that causes single- and double-
stranded DNA breaks. This genotoxin was expected to induce similar responses in A549 
cells as etoposide [27]. A549 cells exposed to MMS experienced a substantial increase 
in the number of apoptotic cells, and this exceeds the decline in mitochondrial activity 
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or loss of membrane activity at this MMS concentration. Apparently, the early stage of 
apoptosis initiated by MMS does not greatly impact mitochondrial succinate dehydroge-
nase activity or membrane integrity. The TC50 values for the A549 cells and the NR8383 
are quite similar, suggesting a fairly ubiquitous alkylating damage. 
Streptolysin O is a bacterial pore-forming agent involved in the pathogenesis of a 
number of gram-positive bacterial species. It binds to cholesterol on the surface of the 
cell membrane; multiple binding events lead to aggregation on the cell surface leading 
to formation of small pores on the cell membrane, leading to cell swelling. 
Results with streptolysin O indicate that it is a potent inhibitor of cell metabolism but 
acts rather slowly. Impact on cell attachment is minimal, and LDH release lags behind 
metabolic inhibition. This is surprising, given the mechanism of action and pore forma-
tion, but suggests a relatively slow acting process in damaging the cell membrane. Mac-
rophages are more sensitive than are epithelial cells with a TC50 nearly an order of mag-
nitude lower than that for epithelial cells; this is likely due to the differing amount of 
cholesterol in these membranes. Macrophages have approximately 364 μg cholesterol/
mg total cell protein [28], whereas A549 cells have approximately 15 μg cholesterol/mg 
protein [29]. The 20- fold higher cholesterol level of the macrophages could account for 
the 9-fold greater sensitivity of the macrophages to streptolysin O. 
Triton destabilizes cell adhesion by solubilizing the cell membrane with complete 
solubilization occurring at concentrations of 2% v/v, corresponding to 32 mM (aver-
age MW=625 D), which is significantly higher than that evaluated here. The hydropho-
bic ends of the detergent bind to the hydrophobic regions of the proteins dislocating 
the lipid molecules. 
The TC50 for A549 cells and NR8383 cells responding to triton is fairly similar (0.09 
mM and 0.05 mM, respectively), suggesting some similarity in the type of damage that is 
caused in each of the cell types. The greater sensitivity of the macrophages could again 
be due to their higher cholesterol content which maintains higher membrane fluidity. 
Both the A549 and NR8383 cells show a step change response to triton within a narrow 
range of concentrations. Only a small amount of apoptosis was detected; however, tri-
ton exposure does lead to initiation of complex responses (Table 1 and [7]). Triton leads 
to substantial increases in the transcription of genes for structural and transport pro-
teins. The effect of triton likely extends beyond just the membrane, and so its use as a 
membranepermeabilizing agent should be utilized cautiously. 
Warfarin is odorless, tasteless, and effective in very low dosages as a preventative of 
blood clotting. Its action is considered to not be rapid. Warfarin acts by inhibiting vita-
min K-dependent coagulation factors and so is also utilized as a pharmaceutical to pre-
vent blood from clotting to treat acute pulmonary embolism, atrial fibrillation, and deep 
vein thrombosis and after a heart attack or stroke to prevent a recurrence. Absorption 
by the lungs may result in hemorrhagic effects. 
Our results with warfarin indicate that it impacts metabolic activity at lower concen-
trations than it impacts membrane integrity. It is a slow-acting agent on A549 cells pro-
ducing a small increase in metabolism after 2 h exposure followed by a decline in mi-
tochondrial activity occurring only after 24 h of exposure. Its low solubility may lead to 
the slow uptake into A549 cells. 
The response of A549 and NR8383 lung-derived cells to these toxins is used as a bio-
logical recognition element in spectroscopic biosensors to detect the presence and iden-
tity of inhalation health hazards [30, 31]. As shown here, both cell types are highly re-
sponsive to a wide range of toxins including those that induce membrane damage, DNA 
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damage, and inhibition of metabolic activity. We have found that membrane damage is 
readily quantified using a fiber-delivered infrared spectroscopic measurement [32–33], 
whereas internal damage may best be quantified through Raman spectroscopic mea-
surements [34]. Macrophages appear to be more sensitive to many of these biotoxins; 
however, their low adherence to surfaces and high variability in response makes their 
use in a biosensor problematic and requires further evaluation. 
Conclusions 
The A549 and NR8383 cells were sensitive to a wide range of biological toxins. Both cell 
types show some response to each toxin after 2 h of exposure (the shortest time tested) 
with the degree of response depending on the concentration of toxicant. The response 
to Triton X-100 was most rapid with nearly all metabolic activity lost in 2.5 h after ex-
posure to amounts above the TC50. This surfactant caused little damage at low concen-
trations but yielded a step change in decline of cell function around the TC50 value. No 
other toxicant showed such a rapid decline in cell function even at the highest concen-
trations tested. Response followed dose-dependent behavior with gradual declines in 
cell function for all compounds other than triton X-100. Gliotoxin was the most potent 
toxicant requiring only micromolar levels to inhibit cellular metabolism and showed a 
substantial interaction between dosage and exposure time with cellular response. 
These studies support the use of A549 and similar cultures as biological recognition 
elements to detect inhalation health hazards. Judicious selection of cell types used in 
cell-based biosensors must be based on application, detection methodology, and envi-
ronmental conditions to which the cells will be subjected. The higher sensitivity of the 
macrophages to these toxins suggests that they may be suitable for use as a biologi-
cal recognition element; however, their low adhesion to surfaces makes their use prob-
lematic for this application.  
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